3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Leukemia
41
Breast Neoplasms
28
Lymphoma
21
Leukemia, Myeloid, Acute
16
Burkitt Lymphoma
13
Myelodysplastic Syndromes
11
Graft vs Host Disease
10
Lymphoma, Non-Hodgkin
7
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Biphenotypic, Acute
7
Squamous Cell Carcinoma of Head and Neck
6
Urinary Bladder Neoplasms
5
Leukemia, Promyelocytic, Acute
5
Hodgkin Disease
5
Anemia, Refractory, with Excess of Blasts
5
Osteosarcoma
4
Myeloproliferative Disorders
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Chronic
4
Head and Neck Neoplasms
4
Arthritis, Rheumatoid
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Interventions
Paclitaxel
23
Carboplatin
22
Capecitabine
18
Gemcitabine
16
130-nm albumin-bound paclitaxel
16
pembrolizumab
14
Cyclophosphamide
12
atezolizumab
9
Epirubicin
9
sacituzumab govitecan
8
Albumin-Bound Paclitaxel
8
eribulin
6
Vinorelbine
6
Drug Therapy
6
Doxorubicin
6
camrelizumab
4
Docetaxel
4
Cisplatin
4
Injections
3
pegfilgrastim
2
olaparib
2
famitinib
2
Filgrastim
2
Everolimus
2
veliparib
1
trilaciclib
1
toripalimab
1
taxane
1
niraparib
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Triple Negative Breast Neoplasms
×
Methotrexate
×
Clear all
NCT00022516
2016-09-16
22-00
ETOP IBCSG Partners Foundation
Phase 3
Completed
1,086 enrolled
10 charts